Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Australia
/
Healthcare
Create a narrative
Australian Clinical Labs Community
ASX:ACL Community
1
Narratives
written by author
0
Comments
on narratives written by author
21
Fair Values set
on narratives written by author
Create a narrative
Australian Clinical Labs
Popular
Undervalued
Overvalued
Community Investing Ideas
Australian Clinical Labs
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
AI And New Genetic Tests Will Drive Future Operational Improvements
Key Takeaways Expansion into genetic molecular testing and operational efficiency initiatives are set to bolster revenue growth and enhance net margins. Strategic acquisitions domestically and internationally offer accelerated growth potential by expanding market share and leveraging synergies.
View narrative
AU$3.78
FV
17.0% undervalued
intrinsic discount
4.80%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
ACL
ACL
Australian Clinical Labs
Your Fair Value
AU$
Current Price
AU$3.14
52.4% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-16m
909m
2015
2018
2021
2024
2025
2027
2030
Revenue AU$909.2m
Earnings AU$38.3m
Advanced
Set Fair Value